Virginia’s health future is about to face major changes — and the next person steering that ship could make all the difference. But here’s where it gets interesting: Governor-elect Abigail Spanberger has tapped a seasoned Washington insider and Virginia policy veteran, Marvin Figueroa, to serve as Secretary of Health and Human Resources (HHR). His appointment signals not just continuity but potential transformation in how the Commonwealth navigates an evolving national healthcare landscape.
Figueroa isn’t new to this world. He previously served as Deputy Secretary of Health and Human Services (HHS) under former Governor Ralph Northam and was a trusted health policy advisor to U.S. Senator Mark Warner. Notably, he helped shape the 2018 CHRONIC Care Act — a law expanding Medicare’s coverage for millions of Americans dealing with chronic illnesses. His most recent chapter took him into the private sector as a vice president at BGR Group, a bipartisan lobbying and strategy firm in Washington, D.C.
As Spanberger’s incoming HHR secretary, Figueroa will oversee more than a dozen major state agencies, including the Departments of Health, Social Services, and Medical Assistance Services. Together, they form the backbone of Virginia’s healthcare system — from child welfare and elderly care to Medicaid administration. In short, this position will be critical to implementing Spanberger’s ambitious public health agenda.
In a statement accompanying the announcement, Spanberger emphasized her commitment to health equity and affordability, saying she wants “leaders who are ready to tackle the tough challenges ahead.” She added, “I know that Mr. Figueroa will always put the health and safety of Virginians first. Together, we’ll work to ensure affordable, accessible care for every community across our Commonwealth.”
And the timing couldn’t be more urgent. Spanberger’s team is stepping in at a moment when the rules of federal healthcare funding are shifting once again. States like Virginia will have to adjust to new Medicaid eligibility requirements and hospital financing models — all consequences of recent federal legislation and budget realignments. Outgoing Governor Glenn Youngkin, sensing potential uncertainty under the returning Trump administration, had already set aside nearly $900 million from Virginia’s surplus to act as a budgetary cushion. A portion of this is expected to offset the costs pushed onto states after Congress’s reconciliation bill, which transferred more responsibility for public health programs to local governments.
Figueroa acknowledged the stakes in his response. “Families are feeling the pressure of rising costs and the frustration of complicated systems,” he said. “I share the Governor-elect’s commitment to meeting these challenges head-on. Our goal is to strengthen the systems people rely on every day and make progress that Virginians can feel in their lives.”
Healthcare affordability and access were cornerstones of Spanberger’s campaign. One of her key proposals involves consolidating Medicaid’s pharmacy benefit management under a single, state-contracted oversight position. Advocates argue this reform would improve transparency, reduce costs, and help independent pharmacies stay viable. But some critics warn that centralization could also limit competition. Is this the kind of structural overhaul Virginia needs — or another layer of bureaucracy?
Other initiatives expected to surface under her leadership include a statewide hospital price transparency database to help consumers compare costs for treatments and prescription drugs. Spanberger also plans to partner with Attorney General-elect Jay Jones to toughen consumer protection laws, while supporting the state’s pharmaceutical manufacturing sector in producing more affordable generic medications. These efforts aim to lessen dependence on large national suppliers and to stabilize local drug prices.
Another major focus will be Virginia’s network of free and charitable clinics, which often serve as a last line of defense for uninsured residents. Spanberger has pledged sustained funding and support for these clinics, many of which are already under financial strain due to fluctuating federal policies. With the possibility of thousands losing coverage under changing eligibility rules, local clinics could soon face overwhelming demand.
So here’s the real question: Will Spanberger and Figueroa’s partnership usher in lasting reform, or will federal headwinds and political friction slow their progress before it begins? Their approach will set the tone for how Virginia navigates not just today’s healthcare challenges, but the uncertain years ahead.
What do you think — is Virginia on the brink of a public health revival, or is this pick too close to Washington’s playbook? Let’s hear your thoughts in the comments.
